EyeGate Pharma Appoints Daniel S. Durrie, MD, and Randall J. Olson, MD, to Scientific Advisory Board

Source: EyeGate Pharma

Monday, March 13, 2017 | Management/Leadership , Eyegate Pharmaceuticals


EyeGate Pharmaceuticals announced the appointment of two leading ophthalmology experts, Daniel S. Durrie, MD, and Randall J. Olson, MD, to its Scientific Advisory Board. Drs. Durrie and Olson will work together with the other members of EyeGate's SAB to provide the company strategic guidance and support the continued development of its ophthalmic platforms, EGP-437 and EyeGate OBG.

"We are proud to welcome Daniel and Randall to the EyeGate's SAB. They are both highly distinguished ophthalmologists with a deep understanding of our target markets," Stephen From, Chief Executive Officer of EyeGate, said in a company news release. "We look forward to leveraging their extensive scientific and clinical expertise as we continue to advance our therapeutic candidates and apply our highly innovative ophthalmic platforms to develop new treatment options for patients in need."
 
Daniel S. Durrie, MD, has more than 30 years of experience in refractive and corneal surgery and is a pioneer in refractive surgery technology and procedures. He is a board-certified ophthalmologist and currently serves as a clinical professor and Director of Refractive Surgery Services at the University of Kansas Medical Center. Dr. Durrie was named one of the 50 "Most Influential Ophthalmologists in the World" by the Cataract and Refractive Surgery Magazine. His research focuses on advancements in vision correction technology. He has participated in over 150 FDA clinical studies and has authored over 150 peer-reviewed scientific journal articles. He received his medical degree and completed his ophthalmology residency at the University of Nebraska, graduating with distinction. He completed a Corneal Fellowship with Filkins Eye Institute in Omaha, Nebraska.
 
Randall J. Olson, MD, is a board-certified ophthalmologist with more than 30 years of experience. Currently, he serves as Chief Executive Officer of the John A. Moran Eye Center andPresidential Endowed Professor at University of Utah School of Medicine. Dr. Olson specializes in research dealing with cataract surgery, intra-ocular lens complications, teleophthalmology and corneal transplantation techniques. He is the author of more than 300 publications, and was selected as one of the 15 best cataract surgeons in the United States by Ophthalmology Times. He received his medical degree from University of Utah School of Medicine and completed his residency in ophthalmology at the University of California - Los Angeles.


Comments

You must be logged in to leave a comment.